What happens to my intellectual property?

The default situation leads to the publication of results in the open access ECBD eventually. The user has the option to request an ‘embargo’ period of up to 36 months to delay the publication of his/her data to allow: In-depth characterization of hits for publication in a scientific peer-reviewed journal and preparing/filing of patents.
All foreground and background IPR stays with those who have contributed to the invention.

Which costs are involved?

If you would like to screen our European Chemical Biology Library (ECBL) with a total of 100.000 compounds, a compound replenishment fee applies:

  • 15.000€ for users from EU-OPENSCREEN member countries (see member countries here)
  • 40.000€ for users from other countries
  • 42.000€ for industry users